Regenesis’ Metals Remediation Compound (MRC®) Recognized with Wall Street Journal Technology Innovation Award
Regenesis Bioremediation Products’ Metals Remediation Compound (MRC®), a low-cost, innovative technology for the rapid removal of toxic metals and chlorinated solvents from groundwater, was recognized in The Wall Street Journal’s 2004 Technology Innovation Awards competition. California-based Regenesis introduced MRC in 2003 and it quickly won acceptance as a highly effective in-situ treatment for removing a wide range of metals from groundwater, while eliminating the need for much more costly and intrusive pump-and-treat systems. Last spring, MRC won the prestigious ICU Innovation Award for 2004, which is presented annually at International Clean Up, one of Europe’s major environmental exhibition and conference.
(PRWEB) November 20, 2004 -- Regenesis Bioremediation Products’ Metals
Remediation Compound (MRC®), a low-cost, innovative technology for the rapid
removal of toxic metals and chlorinated solvents from groundwater, was
recognized in The Wall Street Journal’s 2004 Technology Innovation Awards
competition. Last spring, MRC also received the prestigious ICU Innovation
Award, which is presented annually at International Clean Up, a leading European
environmental exhibition and conference. The winners were announced in all
editions of The Wall Street Journal for November 15, under the heading, “The
Best and the Brightest.”
Over 600 applicants world-wide, including such
high-profile companies as IBM, Xerox, Sun Microsystems and Toyota, competed for
awards in 12 technology categories ranging from “Semiconductors and Electronics”
to “Medical,” “Security,” “Transportation,” and Regenesis’s category,
“Environment.”
The judging favored innovations that successfully broke
with conventional processes and went “beyond marginal improvements in existing
products and services.” Winners were chosen by an independent, international
panel of judges from such organizations as Agilent Laboratories, the Swiss
Federal Institute of Technology, Harvard Medical School, and Siemens AG.
Although commercial viability was not a criterion, MRC had quickly
proven successful in the marketplace following its introduction in 2003 as a
highly effective in-situ treatment for removing a wide range of metals from
groundwater, while eliminating the need for much more costly and intrusive
pump-and-treat systems.
MRC is a non-toxic, viscous material which is
easily injected into the area of contamination using widely available
direct-push equipment. It then reacts with ions of dissolved metals to produce a
harmless metal-organosulfur complex that sorbs strongly to soil particles and
thus becomes immobilized in the subsurface. Over time, bacterial action can
degrade the organic parts of the compound, leaving only benign sulfide solids
that are incorporated into the soil matrix.
Metals treatable with MRC
include chromium, arsenic, copper, nickel, cadmium, lead, mercury, and certain
radionuclides such as uranium and plutonium. These and other dissolved metals
are found in soil and groundwater at thousands of sites in the U.S. and
worldwide due to spills and leaks from steel plants, plating shops and other
industrial facilities, seepage from industrial waste lagoons, and leaching from
landfills, sewage sludge, mine tailings and other sources.
Conventional
remediation approaches require costly, usually intrusive construction,
operations, and maintenance to extract, treat, and dispose of contaminated media
and hazardous wastes. By directly altering geochemical processes instead, MRC
can render these measures unnecessary in many situations.
Applied at a
high-profile Superfund site associated with an industrial plating facility, MRC
removed more than 99% of hexavalent chromium from groundwater in slightly over
three months, at a fraction of the cost of a pump-and-treat cleanup system that
had been in place at the site for ten years.
In another typical
application, treatment with MRC reduced the concentration of cadmium in
groundwater from 17 parts per billion (more than three times the contaminant
level)to below detectable level. MRC also includes a component that accelerates
the natural bioremediation of chlorinated solvents, making it particularly
useful at sites contaminated with solvents as well as toxic metals.
About Regenesis
Incorporated in 1994, Regenesis is the world's
leading developer and distributor of injectable products designed to facilitate
the rapid, low-cost, and efficient cleanup of contaminated-groundwater sites.
Regenesis's patented products include Oxygen Release Compound (ORC®.) and ORC
Advanced™ for remediation of aerobically degradable hydrocarbons; Hydrogen
Release Compound (HRC®.), for treatment of anaerobically degradable compounds;
HRC Extended Release Formula (HRC-X®) for long-term treatment of residual source
areas and DNAPLs; and Bio-Dechlor Inoculum™ for treatment of dichloroethenes
(DCE) and vinyl chloride (VC) at recalcitrant sites. Additional data and a
downloadable file of the MRC® product brochure are available at the Regenesis
website (regenesis.com). For further information, contact Marketing Director
Bryan W. Vigue at 949-366-8000, x122 or by email at e-mail protected from spam
bots.
# # #
Source : http://www.prweb.com/releases/2004/11/prweb180673.htm